DaVita (NYSE:DVA) versus Agilon Health (NYSE:AGL) Head to Head Review

Agilon Health (NYSE:AGL) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Agilon Health and DaVita, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2	6	6	0	2.29
DaVita	0	3	4	0	2.57

Agilon Health currently has a consensus target price of $102.25, suggesting a potential downside of 6.12%. DaVita has a consensus target price of $235.86, suggesting a potential upside of 23.72%. Given DaVita’s stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than Agilon Health.

Insider and Institutional Ownership

90.1% of DaVita shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 1.9% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Agilon Health has a beta of 3.1, indicating that its stock price is 210% more volatile than the S&P 500. Comparatively, DaVita has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

Profitability

This table compares Agilon Health and DaVita’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Agilon Health	-1.45%	-59.42%	-7.29%
DaVita	6.49%	-225.93%	5.42%

Earnings & Valuation

This table compares Agilon Health and DaVita”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$6.00 billion	0.30	-$391.35 million	($5.55)	-19.62
DaVita	$14.17 billion	0.85	$746.80 million	$13.58	14.04

DaVita has higher revenue and earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Summary

DaVita beats Agilon Health on 10 of the 14 factors compared between the two stocks.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.